Skip to main content
Editorial
Will the UK–US pharmaceuticals deal really cause 229,000 excess deaths? A critical appraisal
- Sreeram V Ramagopalan and
- Michael L Ryan
e260186
Published Online:8 September 2026
- This article corrects the following:
Corrigendum
- Journal of Comparative Effectiveness Research
- 19 October 2026
Letter to the Editor
Letter to the Editor: Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema
- Irmgard Andresen,
- Natalie Khutoryansky,
- Sarah L Feeny, and
- Alissa Dangel
e260018
Published Online:19 October 2026
Letter in Reply
Response to Letter to the Editor regarding “Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema”
- Yinglei Li,
- Simona Gavata-Steiger,
- Chiara Nenci,
- Nicolas Scheuer,
- Sarah Walsh,
- Anja Haltner, and
- Imtiaz A Samjoo
e260183
Published Online:19 October 2026
White Paper
Bridging the gap in cell and gene therapy: addressing operational and financial barriers to achieve sustainable access
- Gary L Simmons,
- Robert E Richards,
- Ivan M Borrello,
- Mylove Mortel,
- Joe DePinto, and
- Elias C Pittos
e260075
Published Online:7 October 2026
Methodology
Development and implementation of a living network meta-analysis framework for comparative effectiveness research: a case study in chronic venous insufficiency treatment
- Wendy Wifler,
- Dirk Sutherland,
- Diana Frame,
- Larry Gache, and
- Candace Gunnarsson
e260142
Published Online:8 October 2026
Research Article
On the economics of broadly neutralizing monoclonal antibodies for HIV prevention in high-income countries
- Blythe Adamson,
- Huub C Gelderblom,
- Maurine D Miner, and
- Lawrence Corey
e260120
Published Online:1 October 2026
Real-world utilization of pembrolizumab dosing schedules in Belgium: a multi-center retrospective study using a common data model and natural language processing
- Annelies Verbiest,
- Hans Prenen,
- Annelies Janssens,
- Christof Vulsteke,
- Danielle Delombaerde,
- Laura Tack,
- Philip R Debruyne,
- Iege Bassez,
- Clara L Oeste,
- Agnes Brandtmüller,
- Carl Baxter,
- Pieterjan Debie, and
- Jan Vertriest
e260011
Published Online:21 October 2026
Real-world cost-effectiveness of sequential therapy of in-class transition to ixazomib versus daratumumab for transplant-ineligible newly diagnosed multiple myeloma in China
- Genyong Zuo,
- Aijun Liu,
- Zunmin Zhu,
- Li Bao,
- Lihong Liu,
- Yongbo Gao,
- Wendong Chen,
- Rong Fu, and
- Wenming Chen
e260146
Published Online:13 October 2026
Matching-adjusted indirect comparison of zanubrutinib and real-world chemotherapy, rituximab and chemoimmunotherapy in relapsed or refractory marginal zone lymphoma
- Renata Walewska,
- Kaijun Wang,
- Caitlin Smare,
- Ina Zhang,
- Leyla Mohseninejad,
- Silvy Mardiguian,
- Sam Keeping,
- Kim M Linton, and
- Harriet S Walter
e260132
Published Online:6 October 2026
Comparative cost analysis of Eluvia™ versus Zilver® PTX® in treating femoropopliteal peripheral artery disease utilizing real-world data
- Elizabeth A Genovese,
- Abimbola O Williams,
- Ryoko Sato,
- Alysha M McGovern, and
- Michael R Jaff
e260126
Published Online:21 October 2026
Matching-adjusted indirect treatment comparisons in chronic inflammatory demyelinating polyneuropathy: interpreting current evidence and enhancing future studies
- Batyrkhan Kuatov,
- Barkha P Patel,
- Muhaimen Siddiqui,
- Diana Tran,
- Paul Spin,
- Laurence Undreiner, and
- Shicheng Weng
e260077
Published Online:9 October 2026
Review
Methodological considerations for indirect treatment comparisons of HIV incidence for long-acting injectable pre-exposure prophylaxis
- Tristan Curteis,
- Aidan N Franklin,
- Rebecca K Judge,
- Anna Zolotor,
- James Jarrett,
- Christoph C Carter,
- Ramin Ebrahimi, and
- Dylan Mezzio
e260103
Published Online:15 October 2026
Perspective
Considerations for understanding systematic reviews and network meta-analyses in neurological applications: a review and critique in chronic migraine
- Jessica Ailani,
- Christopher D Saffore,
- Ifeanyi Ubamadu,
- Stefano Perni,
- Elizabeth Chertavian,
- Eric B Collins, and
- Si-Tien Wang
e260119
Published Online:22 September 2026